The Effect of Bifidobacterium animalis ssp. lactis HN019 on Cellular Immune Function in Healthy Elderly Subjects: Systematic Review and Meta-Analysis

• Published in: Nutrients Vol. 9; no. 3; p. 191
• Main Authors: Miller, Larry, Lehtoranta, Liisa, Lehtinen, Markus
• Format: Journal Article
• Language: English
• Published: Switzerland MDPI AG 24.02.2017; MDPI
• Subjects: Aged; Bifidobacterium animalis; Bifidobacterium animalis subsp. lactis; clinical trials; confidence interval; elderly; Healthy Volunteers; Humans; immune response; Immunity, Cellular; Killer Cells, Natural - immunology; Killer Cells, Natural - microbiology; Meta-analysis; natural killer cells; neoplasms; Neutrophils - metabolism; Neutrophils - microbiology; Non-Randomized Controlled Trials as Topic; Older people; Phagocytes - immunology; Phagocytes - microbiology; Probiotics; Probiotics - administration & dosage; Randomized Controlled Trials as Topic; Review; Systematic review; probiotic; Bifidobacterium; aging; immunity; elderly
• ISSN: 2072-6643; 2072-6643
• DOI: 10.3390/nu9030191

Elderly people have increased susceptibility to infections and cancer that are associated with decline in cellular immune function. The objective of this work was to determine the efficacy of Bifidobacterium (B.) animalis ssp. lactis HN019 (HN019) supplementation on cellular immune activity in healthy elderly subjects. We conducted a systematic review of Medline and Embase for controlled trials that reported polymorphonuclear (PMN) cell phagocytic capacity or natural killer (NK) cell tumoricidal activity following B. lactis HN019 consumption in the elderly. A random effects meta-analysis was performed with standardized mean difference (SMD) and 95% confidence interval between probiotic and control groups for each outcome. A total of four clinical trials were included in this analysis. B. lactis HN019 supplementation was highly efficacious in increasing PMN phagocytic capacity with an SMD of 0.74 (95% confidence interval: 0.38 to 1.11, p < 0.001) and moderately efficacious in increasing NK cell tumoricidal activity with an SMD of 0.43 (95% confidence interval: 0.08 to 0.78, p = 0.02). The main limitations of this research were the small number of included studies, short-term follow-up, and assessment of a single probiotic strain. In conclusion, daily consumption of B. lactis HN019 enhances NK cell and PMN function in healthy elderly adults.